"10.1371_journal.pone.0148255","plos one","2016-02-03T00:00:00Z","Garabet G Toby; Tongyao Liu; Yang Buyue; Xin Zhang; Alan J Bitonti; Glenn F Pierce; Jurg M Sommer; Haiyan Jiang; Robert T Peters","Biogen, Cambridge, MA, United States of America","Conceived and designed the experiments: GT TL YB AB GP JS HJ RP. Performed the experiments: GT TL YB XZ. Analyzed the data: GT TL YB JS HJ RP. Wrote the paper: GT TL YB RP.","This study was funded by Biogen. Garabet G. Toby, Tongyao Liu, Yang Buyue, Xin Zhang, Alan J. Bitonti, Glenn F. Pierce, Jurg M. Sommer, Haiyan Jiang, and Robert T. Peters were employees of and held equity interest in Biogen at the time of this research. This work is directly related to the marketed product, ALPROLIX® (rFIXFc), and several of the authors are named as inventors on a number of patents and pending applications covering rFIXFc, filed in the US and throughout the world (for example, US Patent Nos. 7,404,956; 7,348,004; 7,862,820; 8,329,182; and 8,932,830: “Immunoglobulin chimeric monomer-dimer hybrids”; and USSN 13/793,796: “Factor IX polypeptides and methods of use thereof”). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","02","Garabet G Toby","GGT",9,TRUE,8,4,6,4,TRUE,TRUE,FALSE,0,NA,FALSE
